Mark D Lyttle1, Ronan O'Sullivan2, Iolo Doull3, Stuart Hartshorn4, Ian Morris5, Colin V E Powell6. 1. Academic Department of Emergency Care, University of the West of England, Bristol, UK Emergency Department, Bristol Royal Hospital for Children, Bristol, UK. 2. Department of Emergency Medicine, Cork University Hospital, Cork, Ireland School of Medicine, University College Cork, Cork, Ireland Paediatric Emergency Research Unit (PERU), National Children's Research Centre, Dublin 12, Ireland. 3. Department of Paediatric Respiratory Medicine and Specialist Cystic Fibrosis Centre, Children's Hospital for Wales, Cardiff, UK. 4. Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. 5. Children's Hospital for Wales, Wales Deanery, Cardiff, UK. 6. Department of Child Health, Children's Hospital for Wales, Cardiff, UK Department of Child Health, Children's Hospital for Wales, Cardiff, UK.
Abstract
OBJECTIVE: National clinical guidelines for childhood wheeze exist, yet despite being one of the most common reasons for childhood emergency department (ED) attendance, significant variation in practice occurs in other settings. We, therefore, evaluated practice variations of ED clinicians in the UK and Ireland. DESIGN: Two-stage survey undertaken in March 2013. Stage one examined department practice and stage two assessed ED consultant practice in acute childhood wheeze. Questions interrogated pharmacological and other management strategies, including inhaled and intravenous therapies. SETTING AND PARTICIPANTS: Member departments of Paediatric Emergency Research in the United Kingdom and Ireland and ED consultants treating children with acute wheeze. RESULTS: 30 EDs and 183 (81%) clinicians responded. 29 (97%) EDs had wheeze guidelines and 12 (40%) had care pathways. Variation existed between clinicians in dose, timing and frequency of inhaled bronchodilators across severities. When escalating to intravenous bronchodilators, 99 (54%) preferred salbutamol first line, 52 (28%) magnesium sulfate (MgSO4) and 27 (15%) aminophylline. 87 (48%) administered intravenous bronchodilators sequentially and 30 (16%) concurrently, with others basing approach on case severity. 146 (80%) continued inhaled therapy after commencing intravenous bronchodilators. Of 170 who used intravenous salbutamol, 146 (86%) gave rapid boluses, 21 (12%) a longer loading dose and 164 (97%) an ongoing infusion, each with a range of doses and durations. Of 173 who used intravenous MgSO4, all used a bolus only. 41 (24%) used non-invasive ventilation. CONCLUSIONS: Significant variation in ED consultant management of childhood wheeze exists despite the presence of national guidance. This reflects the lack of evidence in key areas of childhood wheeze and emphasises the need for further robust multicentre research studies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: National clinical guidelines for childhood wheeze exist, yet despite being one of the most common reasons for childhood emergency department (ED) attendance, significant variation in practice occurs in other settings. We, therefore, evaluated practice variations of ED clinicians in the UK and Ireland. DESIGN: Two-stage survey undertaken in March 2013. Stage one examined department practice and stage two assessed ED consultant practice in acute childhood wheeze. Questions interrogated pharmacological and other management strategies, including inhaled and intravenous therapies. SETTING AND PARTICIPANTS: Member departments of Paediatric Emergency Research in the United Kingdom and Ireland and ED consultants treating children with acute wheeze. RESULTS: 30 EDs and 183 (81%) clinicians responded. 29 (97%) EDs had wheeze guidelines and 12 (40%) had care pathways. Variation existed between clinicians in dose, timing and frequency of inhaled bronchodilators across severities. When escalating to intravenous bronchodilators, 99 (54%) preferred salbutamol first line, 52 (28%) magnesium sulfate (MgSO4) and 27 (15%) aminophylline. 87 (48%) administered intravenous bronchodilators sequentially and 30 (16%) concurrently, with others basing approach on case severity. 146 (80%) continued inhaled therapy after commencing intravenous bronchodilators. Of 170 who used intravenous salbutamol, 146 (86%) gave rapid boluses, 21 (12%) a longer loading dose and 164 (97%) an ongoing infusion, each with a range of doses and durations. Of 173 who used intravenous MgSO4, all used a bolus only. 41 (24%) used non-invasive ventilation. CONCLUSIONS: Significant variation in ED consultant management of childhood wheeze exists despite the presence of national guidance. This reflects the lack of evidence in key areas of childhood wheeze and emphasises the need for further robust multicentre research studies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
Accident & Emergency; General Paediatrics; Pharmacology; Respiratory
Authors: Nienke J Vet; Brenda C M de Winter; Muriel Koninckx; Shelley A Boeschoten; Annemie L M Boehmer; Jacintha T Verhallen; Frans B Plötz; Anja A Vaessen-Verberne; Bart C H van der Nagel; Catherijne A J Knibbe; Corinne M P Buysse; Saskia N de Wildt; Birgit C P Koch; Matthijs de Hoog Journal: Clin Pharmacokinet Date: 2020-02 Impact factor: 6.447
Authors: Simon Craig; Franz E Babl; Stuart R Dalziel; Charmaine Gray; Colin Powell; Khalid Al Ansari; Mark D Lyttle; Damian Roland; Javier Benito; Roberto Velasco; Julia Hoeffe; Diana Moldovan; Graham Thompson; Suzanne Schuh; Joseph J Zorc; Maria Kwok; Prashant Mahajan; Michael D Johnson; Robert Sapien; Kajal Khanna; Pedro Rino; Javier Prego; Adriana Yock; Ricardo M Fernandes; Indumathy Santhanam; Baljit Cheema; Gene Ong; Shu-Ling Chong; Andis Graudins Journal: Trials Date: 2020-01-13 Impact factor: 2.279
Authors: Simon Craig; Colin V E Powell; Gillian M Nixon; Ed Oakley; Jason Hort; David S Armstrong; Sarath Ranganathan; Amit Kochar; Catherine Wilson; Shane George; Natalie Phillips; Jeremy Furyk; Ben Lawton; Meredith L Borland; Sharon O'Brien; Jocelyn Neutze; Anna Lithgow; Clare Mitchell; Nick Watkins; Domhnall Brannigan; Joanna Wood; Charmaine Gray; Stephen Hearps; Emma Ramage; Amanda Williams; Jamie Lew; Leonie Jones; Andis Graudins; Stuart Dalziel; Franz E Babl Journal: BMJ Open Respir Res Date: 2022-03
Authors: Simon S Craig; Stuart R Dalziel; Colin Ve Powell; Andis Graudins; Franz E Babl; Carole Lunny Journal: Cochrane Database Syst Rev Date: 2020-08-05